(PharmaNewsWire.Com, November 21, 2017 ) In this region, The APAC IUCD devices market is projected to reach USD 2,533.9 million by 2024, from USD 2,161.5 million in 2016 growing at a CAGR of 2.0% in the forecast period 2017 to 2024.
Based on geography, the APAC IUCD devices market is segmented into 11 geographical regions, such as, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of APAC.
APAC IUCD devices market competition by top players including- Bayer AG dominated the IUCD devices market, followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. Also Medigen Distribution, Inc. and Allergen PLC are expected to hold respectively. Some of the other players in this market include DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA SMB Corporation Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, Injeflex Ind And Com Ltda, Bersil, Amed
The APAC intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography. The APAC intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD. On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare.
Companies Mentioned: DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA SMB Corporation Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP
Table of Content: 1. Introduction 2. Market Segmentation 3. Market Overview 4. Executive Summary 5. Premium Insights 6. Asia Pacific Intra-Uterine Contraceptive (Iucd) Devices Market, 7. Asia Pacific Intra-Uterine Contraceptive (Iucd) Devices Market, 8. Asia Pacific Intra-Uterine Contraceptive (Iucd) Devices Market, Company Share 9. Company Profiles
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
